The SCIENTIFIC BREAKTHROUGH OF THE WEEK
GLP-1 Receptor Agonist for Cardiovascular Risk Reduction
Semaglutide (Wegovy), a GLP-1 receptor agonist, has now received expanded approval for cardiovascular risk reduction. Evidence from the landmark SELECT trial demonstrates a
As a participant of the IFUMSA Creatives Academy organized by the Office of the PRO, IFUMSA, and a student of the Content/Creative Writing Skill Track, this week’s assessment is to write and publish a 300-word blog-style article. Here’s mine @IfumsaOau@simply_idera
This year’s International Day of the Girl Child isn’t just a celebration; it’s a movement.
Join us for an inspiring conversation themed “The Girl I Am, The Change I Lead: Girls on the Frontline of Crisis.”
Join the WhatsApp group now!!
https://t.co/T8444w8pAm
🔴NEW MEDICAL RESEARCH OPPORTUNITY
Medical Students, IMGs, AMGs, Residents, Fellows, Hospitalists & Physicians
We are conducting 12 NARRATIVE REVIEW Studies & 5 META-ANALYSIS & 2 Original CDC Database Research Modules in Ocotber/November 2025
We aim to train beginners under the supervision of mentors from great Institutes.
We will also assist in presenting the abstracts at the conferences.
Modules available for the following Medical Specialties :
Internal medicine, family medicine, pediatrics, general surgery, orthopedic surgery, neurosurgery, plastic surgery, cardiology, neurology, psychiatry, emergency medicine, critical care medicine, anesthesiology, radiology, dermatology, gastroenterology, endocrinology, nephrology, rheumatology, hematology-oncology, pulmonology, infectious diseases, obstetrics and gynecology (OB-GYN), urology, otolaryngology (ENT), ophthalmology, pathology, allergy and immunology, sports medicine, palliative care, nuclear medicine, occupational medicine, preventive medicine, and rehabilitation medicine (PM& R)
DM or Comment your specialty to enroll.